ELEVENTH SUPPLEMENTAL INDENTURESupplemental Indenture • June 25th, 2007 • Quest Diagnostics Inc • Services-medical laboratories • New York
SUPPLEMENTAL INDENTURE dated as of June 22, 2007 (this “Eleventh Supplemental Indenture”), among AMERIPATH OHIO, INC., TID ACQUISITION CORP. and AMERIPATH, INC., each a Delaware corporation, DERMATOPATHOLOGY SERVICES, INC. and SHOALS PATHOLOGY ASSOCIATES, INC., each an Alabama corporation, AMERIPATH CONSOLIDATED LABS, INC. and AMERIPATH MARKETING USA, INC., each a Florida corporation, AMERIPATH KENTUCKY, INC., a Kentucky corporation, AMERIPATH MICHIGAN, INC., a Michigan corporation, PCA OF DENVER, INC. and PCA OF NASHVILLE, INC., each a Tennessee corporation, AMERIPATH MISSISSIPPI, INC., a Mississippi corporation, AMERIPATH NORTH CAROLINA, INC., a North Carolina corporation, AMERIPATH PHILADELPHIA, INC., a New Jersey corporation, ANATOMIC PATHOLOGY SERVICES, INC., an Oklahoma corporation, ARIZONA PATHOLOGY GROUP, INC., an Arizona corporation, AMERIPATH SC, INC., a South Carolina corporation, AMERIPATH YOUNGSTOWN LABS, INC., an Ohio corporation, OCMULGEE MEDICAL PATHOLOGY ASSOCIATION, I
QUEST DIAGNOSTICS INCORPORATED, as Issuer THE SUBSIDIARY GUARANTORS NAMED HEREIN, as Subsidiary Guarantors and THE BANK OF NEW YORK, as Trustee Tenth Supplemental Indenture Dated as of June 22, 2007Tenth Supplemental Indenture • June 25th, 2007 • Quest Diagnostics Inc • Services-medical laboratories • New York
Modifications. Each Subsidiary Guarantor agrees that (a) the time or place of payment of the Guarantor Obligations may be changed or extended, in whole or in part, to a time certain or otherwise, and may be renewed or accelerated, in whole or in part; (b) the Company and any other party liable for payment under the Indenture or under the Note may be granted indulgences generally; (c) any of the provisions of this Note or the Indenture may be modified, amended or waived; and (d) any party (including any Subsidiary Guarantor) liable for the payment under this Note or under the Indenture may be granted indulgences or be released; all without notice to or further assent by such Subsidiary Guarantor, which shall remain bound thereon, notwithstanding any such exchange, compromise, surrender, extension, renewal, acceleration, modification, indulgence or release.
TWELFTH SUPPLEMENTAL INDENTURESupplemental Indenture • June 25th, 2007 • Quest Diagnostics Inc • Services-medical laboratories • New York
SUPPLEMENTAL INDENTURE dated as of June 25, 2007 (this “Twelfth Supplemental Indenture”), among AMERIPATH GROUP HOLDINGS, INC., AMERIPATH HOLDINGS, INC., AMERIPATH INTERMEDIATE HOLDINGS, INC. (the “Additional AmeriPath Subsidiaries”) and MEDPLUS, INC. (“MedPlus”) each a Delaware corporation (the Additional AmeriPath Subsidiaries, together with MedPlus, the “Additional Subsidiary Guarantors”), QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation (the “Company”), and THE BANK OF NEW YORK, a New York banking corporation, as Trustee (the “Trustee”).
